申请人:A. H. Robins Company, Incorporated
公开号:US05236931A1
公开(公告)日:1993-08-17
This invention provides novel 3-quinuclidinyl benzamides and benzoates which have utility as therapeutical agents which exhibit anxiolytic, antipsychotic, cognition improvement, antiemetic and gastric prokinetic effects in warm blooded animals. The compounds useful in the methods and composition of this invention are represented by the formula: ##STR1## where X is oxygen or sulfur; Y is --NH or --O--; when Y is --O--, R.sup.1 is ##STR2## and when Y is --NH, R.sup.1 is ##STR3## and R.sup.2 is hydrogen, C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkenyl; the geometrical and optical isomers, or a pharmaceutically acceptable salt thereof.
这项发明提供了新颖的3-喹诺啉基苯甲酰胺和苯甲酸酯,其具有作为治疗剂的用途,对温血动物表现出抗焦虑、抗精神病、认知改善、抗恶心和胃动力促进作用。本发明的方法和组合物中有用的化合物由以下公式表示:##STR1## 其中X为氧或硫;Y为--NH或--O--;当Y为--O--时,R1为##STR2##,当Y为--NH时,R1为##STR3##,且R2为氢、C1-C4烷基或C1-C4烯基;其几何和光学异构体,或其药学上可接受的盐。